Drugs – SeekHealthZ

Marstacimab

Seekhealthz Editorial — Wed, 02 Jul 2025 18:13:10 +0000

Marstacimab – Description Indications & Dosage NOTE: Marstacimab is designated as an orphan drug by the FDA for this indication. Subcutaneous dosage Adults weighing 50 kg or more: 300 mg subcutaneously as a single dose, then 150 mg subcutaneously once weekly starting 1 week after the loading dose. Consider increasing the dose to 300 mg …

Marstacimab Read More »

Olutasidenib

Seekhealthz Editorial — Wed, 25 Jun 2025 09:45:25 +0000

Olutasidenib – Description Indications & Dosage For the treatment of acute myelogenous leukemia (AML) NOTE: The FDA has designated olutasidenib as an orphan drug for the treatment of AML. for the treatment of relapsed or refractory AML with an isocitrate dehydrogenase-1 (IDH1) mutation NOTE: Evaluate patients for the presence of the IDH1 mutation in the blood …

Olutasidenib Read More »

Odevixibat

Seekhealthz Editorial — Tue, 24 Jun 2025 07:26:19 +0000

Odevixibat – Description Indications & Dosage For the treatment of progressive familial intrahepatic cholestasis-associated pruritus NOTE: Odevixibat may not be effective in progressive familial intrahepatic cholestasis (PFIC) type 2 patients with ABCB11 variants resulting in nonfunctional or complete absence of bile salt export pump protein (BSEP-3).66816 Oral dosage (capsules) Adults: 40 mcg/kg/dose PO once daily in …

Odevixibat Read More »

Relugolix

Seekhealthz Editorial — Sat, 21 Jun 2025 07:10:52 +0000

Relugolix – Description Indications & Dosage For use in radionuclide myocardial perfusion imaging for coronary artery disease diagnosis in patients unable to undergo adequate exercise stress Intravenous dosage Adults: 0.4 mg IV once.33906 Maximum Dosage Limits: •Adults 0.4 mg IV single dose. •Geriatric 0.4 mg IV single dose. •Adolescents Safety and efficacy have not been established. •Children …

Relugolix Read More »

Nipocalimab

Seekhealthz Editorial — Fri, 20 Jun 2025 18:20:56 +0000

Nipocalimab – Description Indications & Dosage Prior to nipocalimab initiation For the treatment of generalized myasthenia gravis in individuals who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuKS) antibody positive NOTE: Nipocalimab is designated as an orphan drug by the FDA for this indication. Intravenous dosage Adults: 30 mg/kg IV infusion over 30 minutes as a …

Nipocalimab Read More »

Nogapendekin alfa inbakicept

Seekhealthz Editorial — Thu, 19 Jun 2025 07:00:48 +0000

Nogapendekin alfa inbakicept – Description Indications & Dosage For the treatment of bladder cancer For the treatment of Bacillus Calmette-Guerin (BCG)-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors, in combination with BCG Maximum Dosage Limits: •Adults 400 mcg intravesically. •Geriatric 400 mcg intravesically. •Adolescents Safety and efficacy have …

Nogapendekin alfa inbakicept Read More »

Nifurtimox

Seekhealthz Editorial — Wed, 18 Jun 2025 16:44:50 +0000

Nifurtimox – Description Indications Dosage General dosing information: This drug may also have activity against the following microorganisms: Trypanosoma brucei gambiense, Trypanosoma cruzi NOTE: Some organisms may not have been adequately studied during clinical trials; therefore, exclusion from this list does not necessarily negate the drug’s activity against the organism. For the treatment of American trypanosomiasis (Chagas disease) …

Nifurtimox Read More »

Nedosiran

Seekhealthz Editorial — Tue, 17 Jun 2025 17:42:45 +0000

Nedosiran – Description Indications & Dosage For the treatment of primary hyperoxaluria type 1 Note: Nedosiran has been designated as an orphan drug for this indication by the FDA. Subcutaneous dosage Adults weighing 50 kg or more: 160 mg subcutaneously once monthly.69571 Adults weighing less than 50 kg: 128 mg subcutaneously once monthly.69571 Children and Adolescents …

Nedosiran Read More »

Nadofaragene Firadenovec

Seekhealthz Editorial — Mon, 16 Jun 2025 04:33:32 +0000

Nadofaragene Firadenovec – Description Indications & Dosage For the treatment of bladder cancer For the treatment of high-risk Bacillus Calmette-Guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors Precautions Pregnancy Lactation Interactions Adverse Reactions Administration Mechanism of Action Pharmacokinetics •Route-Specific Pharmacokinetics Other Route(s) Intravesical Administration Monitoring Parameters Classifications …

Nadofaragene Firadenovec Read More »

Oliceridine

Seekhealthz Editorial — Sun, 01 Jun 2025 05:29:25 +0000

Oliceridine – Description Indications & Dosage Maximum Dosage Limits: •Adults 3 mg/dose IV and 27 mg/day IV. •Geriatric 3 mg/dose IV and 27 mg/day IV. •Adolescents Safety and efficacy have not been established. •Children Safety and efficacy have not been established. •Infants Safety and efficacy have not been established. •Neonates Safety and efficacy have not …

Oliceridine Read More »